|
RAB18 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.75559999660413E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.96020035945355E-10 |
| Normal-vs-Stage2 |
1.847520E-04 |
| Normal-vs-Stage3 |
1.775830E-02 |
| Normal-vs-Stage4 |
6.718800E-03 |
| Stage1-vs-Stage2 |
4.570600E-01 |
| Stage1-vs-Stage3 |
1.512580E-01 |
| Stage1-vs-Stage4 |
3.896800E-01 |
| Stage2-vs-Stage3 |
6.349200E-01 |
| Stage2-vs-Stage4 |
7.471400E-01 |
| Stage3-vs-Stage4 |
9.227800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.9683002984201E-10 |
| Normal-vs-AfricanAmerican |
1.5096099999945E-05 |
| Normal-vs-Asian |
6.650000E-01 |
| Caucasian-vs-AfricanAmerican |
3.949800E-01 |
| Caucasian-vs-Asian |
9.905700E-02 |
| AfricanAmerican-vs-Asian |
2.333400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.00970010130652E-10 |
| Normal-vs-Female |
2.064200E-02 |
| Male-vs-Female |
3.495800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.10780000004163E-06 |
| Normal-vs-Extreme_Weight |
1.82969972506442E-10 |
| Normal-vs-Obese |
1.50103999999596E-05 |
| Normal-vs-Extreme_Obese |
4.052300E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.664200E-01 |
| Normal_Weight-vs-Obese |
3.592600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.052200E-01 |
| Extreme_Weight-vs-Obese |
8.819600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.525000E-01 |
| Obese-vs-Extreme_Obese |
8.968600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.305700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.83040000051516E-07 |
| Normal-vs-Age(61-80Yrs) |
2.34889996342247E-10 |
| Normal-vs-Age(81-100Yrs) |
1.50455999999854E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.511400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.564300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.651700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.430400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.245000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.971600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.4383994823296E-10 |
| Normal-VS-Type2 PRCC |
2.33269999999619E-05 |
| Normal-VS-KIRP CIMP |
2.526000E-01 |
| Normal-VS-Unclassified PRCC |
1.787900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.298800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.441700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.180200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.636000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.141400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.319600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.34420000003277E-06 |
| Normal-vs-N1 |
1.219020E-03 |
| Normal-vs-N2 |
4.096500E-03 |
| N0-vs-N1 |
6.529200E-01 |
| N0-vs-N2 |
7.713200E-01 |
| N1-vs-N2 |
5.958200E-01 |
|
|
